Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
BörsenkürzelTFX
Name des UnternehmensTeleflex Inc
IPO-datumMar 17, 1980
CEOKelly (Liam J)
Anzahl der mitarbeiter14100
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse550 E Swedesford Rd
StadtWAYNE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19087
Telefon16102256800
Websitehttps://www.teleflex.com/usa/en/#
BörsenkürzelTFX
IPO-datumMar 17, 1980
CEOKelly (Liam J)